The need for this booster has not been established. Historically, annual revaccination with a single dose has been recommended for this product. The presence of maternal antibody is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals. All dogs should initially receive one dose of this product and a second dose 2 to 3 weeks later. If blood enters the syringe freely, choose another injection site. IMPORTANT NOTE: Before injecting vaccine, pull back slightly on syringe plunger. Do not inject directly into blood vessel (see note below). Subcutaneous administration: Lift the loose skin behind the neck or behind the front leg and insert needle (see illustration, arrows 1 and 2). Withdraw entire contents into the syringe. Aseptically rehydrate the vaccine cake with 1 mL of sterile diluent supplied. Gentamicin added as preservative.ĭirections and dosage: Open the syringe by twisting or tapping the cap against a hard surface to break the heat weld. This product contains a CPV2b strain which has been demonstrated effective against disease caused by CPV2c in puppies with maternal antibody. For more information regarding efficacy and safety data go to .Ĭomposition: Canine Spectra ® 5 vaccine is a combination of immunogenic, attenuated strains of CDV, CAV2, CPIV, and CPV type 2b, propagated in cell line tissue cultures The CAV2 fraction has been shown to be effective against disease due to CAV1. The duration of immunity of this product has not been determined. Indications: This product has been shown to be effective for the vaccination of healthy dogs 6 weeks of age or older against canine distemper virus (CDV), infectious canine hepatitis (CAV1), canine adenovirus type 2 (CAV2), canine parainfluenza (CPIV), and canine parvovirus (CPV). Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |